The Department of Translational Hematology and Oncology Research (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.

Based on the most current scientific standards, THOR researchers apply advances in the laboratory to provide the highest level of care for patients.

More information can be found at